NJ State Employees Deferred Compensation Plan’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-9,000
Closed -$700K 134
2025
Q3
$700K Hold
9,000
0.08% 241
2025
Q2
$704K Hold
9,000
0.08% 219
2025
Q1
$652K Hold
9,000
0.08% 222
2024
Q4
$666K Hold
9,000
0.08% 234
2024
Q3
$594K Hold
9,000
0.07% 258
2024
Q2
$831K Hold
9,000
0.1% 193
2024
Q1
$860K Hold
9,000
0.11% 193
2023
Q4
$686K Hold
9,000
0.09% 222
2023
Q3
$624K Hold
9,000
0.09% 219
2023
Q2
$849K Hold
9,000
0.12% 184
2023
Q1
$745K Hold
9,000
0.11% 200
2022
Q4
$671K Hold
9,000
0.11% 200
2022
Q3
$744K Hold
9,000
0.13% 177
2022
Q2
$856K Hold
9,000
0.14% 164
2022
Q1
$1.06M Hold
9,000
0.14% 155
2021
Q4
$1.17M Hold
9,000
0.15% 154
2021
Q3
$1.02M Hold
9,000
0.14% 161
2021
Q2
$932K Hold
9,000
0.12% 177
2021
Q1
$753K Hold
9,000
0.11% 204
2020
Q4
$821K Hold
9,000
0.13% 166
2020
Q3
$718K Hold
9,000
0.13% 161
2020
Q2
$622K Hold
9,000
0.12% 176
2020
Q1
$566K Hold
9,000
0.13% 148
2019
Q4
$700K Hold
9,000
0.12% 179
2019
Q3
$660K Hold
9,000
0.12% 170
2019
Q2
$554K Hold
9,000
0.1% 215
2019
Q1
$574K Buy
+9,000
New +$514K 0.1% 210

Other funds holding EW

NJ State Employees Deferred Compensation Plan's EW Position: Q4 2025 in Review

NJ State Employees Deferred Compensation Plan sold out of Edwards Lifesciences (EW) in Q4 2025, closing a stake of 9,000 shares — an estimated $700K sold.

NJ State Employees Deferred Compensation Plan first reported a position in EW in Q1 2019 and held it in 27 quarters. The position peaked at $1.17M in Q4 2021. 1,313 funds tracked by Wall St. Rank hold EW as of Q4 2025.

  • NJ State Employees Deferred Compensation Plan reported no remaining Edwards Lifesciences position as of Q4 2025 after selling out during the quarter.
  • NJ State Employees Deferred Compensation Plan sold 9,000 Edwards Lifesciences shares in Q4 2025, an estimated $700K.
  • NJ State Employees Deferred Compensation Plan first reported a position in Edwards Lifesciences in Q1 2019 and held it in 27 quarters.
  • NJ State Employees Deferred Compensation Plan's Edwards Lifesciences position peaked at $1.17M in Q4 2021.
  • 1,313 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q4 2025.

Based on NJ State Employees Deferred Compensation Plan's 13F filing for Q4 2025.